Role of Heme Oxygenase-1 (HO-1) in the Pathogenesis of Hypertension among Young Adults: Association with Oxidative Stress, Inflammatory Markers, and Metabolic Profile

Crossmark

Article Sidebar

Page Numbers: 317-338
Download PDF
Published: Aug 18, 2026
Digital Object Identifier: 10.58578/ajcmpr.v3i3.11826
Save this to:
Save to Mendeley Download RIS

Article Metrics:
Viewed: 0 times
Downloaded: 0 times
Article can trace at:

Author Fee:
Free Publication Fees for Foreign Researchers (USD 0.00)
Check for article on SINTA:

LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers

Connected Papers:
Connected Papers


Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.


Authors:
Maijidda Abubakar Musa1*, Kehinde Samuel Olaniyi2, Abdulkadir Aminu Dauda3, Stephanie Esosa Areloegbe4, Sadiya Gambo Mustapha5
Copyright :

Authors retain copyright and grant the journal right of first publication.

Explore Our Journals
Find the journal that best fits your research. If this journal does not match your manuscript’s scope, explore our portfolio below to select a more suitable publication venue.

Main Article Content

Maijidda Abubakar Musa
Kehinde Samuel Olaniyi
Federal University of Health Sciences Azare, Nigeria
Abdulkadir Aminu Dauda
Federal University of Health Sciences Azare, Nigeria
Stephanie Esosa Areloegbe
Afe Babalola University Ado Ekiti, Nigeria
Sadiya Gambo Mustapha
Bayero University Kano, Nigeria

Abstract

Hypertension in young adults is increasingly recognized as a multifactorial condition associated with oxidative stress, inflammation, endothelial dysfunction, and metabolic imbalance. This study investigated the relationship between heme oxygenase-1 (HO-1) and hypertension among young adults, with particular attention to oxidative stress markers, inflammatory mediators, and metabolic profiles. A case–control study was conducted involving 170 hypertensive and normotensive participants. Sociodemographic and clinical characteristics were assessed alongside blood pressure, body mass index (BMI), body weight, and biochemical markers, including HO-1, vascular endothelial growth factor (VEGF), insulin, nitric oxide (NO), iron, and adenosine deaminase (ADA). Compared with normotensive controls, hypertensive participants had significantly higher systolic and diastolic blood pressure (p < 0.05), as well as higher BMI and body weight. HO-1 concentrations were markedly lower in hypertensive participants (p < 0.00001), indicating reduced antioxidant capacity. Conversely, VEGF concentrations were significantly elevated (p < 0.00001), consistent with altered vascular regulation. Hypertensive participants also exhibited increased insulin concentrations (p < 0.01), reduced NO concentrations (p < 0.00001), and elevated iron and ADA concentrations (p < 0.00001), collectively reflecting metabolic dysregulation, impaired endothelial function, oxidative stress, and inflammatory activity. Correlation analysis revealed no significant associations between HO-1 and adenosine, ADA, or xanthine oxidase (p > 0.05). These findings identify a distinct biochemical profile of young-adult hypertension characterized by reduced HO-1 and NO concentrations alongside increased VEGF, insulin, iron, and ADA concentrations. Although the case–control design does not establish causality, the results highlight HO-1 as a relevant component of the oxidative and vascular alterations associated with hypertension and support further longitudinal and mechanistic investigation.

Keywords:
Share Article:

Citation Metrics:

Scopus

Citation Metrics & Similar Scopus Articles

Citation data unavailable from the configured source
Check Secondary Documents in Scopus
Open this article in Scopus, then check the Secondary documents tab. Use Manual Citation Fallback only for counts you have verified manually.
Open in Scopus
Similar Scopus Articles
Scopus
  1. Liu Q. (2027)
    Elucidating the Respective Roles of Photochemical and Photothermal Effects in Photocatalytic Methanol Decomposition
    Nano Micro Letters, 19(1)
  2. Esmaeelpour E. (2027)
    The role of semantic transparency in lexical processing of head-first endocentric compounds in Persian
    Language Related Research, 17(4), 231-261
  3. Feng X. (2027)
    Designing Efficient Inverted Perovskite Solar Cells with Self-Assembled Monolayer Hole Transport Layers
    Nano Micro Letters, 19(1)

Article Details

How to Cite
Musa, M. A., Olaniyi, K. S., Dauda, A. A., Areloegbe, S. E., & Mustapha, S. G. (2026). Role of Heme Oxygenase-1 (HO-1) in the Pathogenesis of Hypertension among Young Adults: Association with Oxidative Stress, Inflammatory Markers, and Metabolic Profile. African Journal of Clinical Medicine and Pharmacy Research, 3(3), 317-338. https://doi.org/10.58578/ajcmpr.v3i3.11826

References

Below is the APA 7–standardized version. Entries using “et al.”, incomplete publication details, or unusual author metadata require confirmation against the original sources.

Akhigbe, R. E., & Ajayi, A. F. (2021). The impact of reactive oxygen species in the development of cardiometabolic disorders: A review. Lipids in Health and Disease, 20, Article 23. https://doi.org/10.1186/s12944-021-01435-7

Aluia, M., Kuntić, M., Daiber, A., Lagrange, J., & Wenzel, P. (2024). Conditional over-expression of heme oxygenase 1 in myelomonocytic cells reduces AngII-induced hypertension and vascular inflammation in mice. European Heart Journal, 45. https://doi.org/10.1093/eurheartj/ehae666.2527

Aluia, M., Kuntić, M., Jurk, K., Daiber, A., Reinhardt, C., Lagrange, J., & Wenzel, P. (2022). Conditional over-expression of heme oxygenase 1 in myelomonocytic cells reduces hypertension and vascular inflammation. European Heart Journal, 43. https://doi.org/10.1093/eurheartj/ehac544.2223

Aluia, M., Luo, Q., Kuntić, M., Finger, S., Lehmann, A., Molitor, M., Assmann, M., Daiber, A., Lagrange, J., & Wenzel, P. (2025). Conditional over-expression of heme oxygenase 1 attenuates vascular inflammation and prevents heart failure in mice with excess neurohormonal activation. European Heart Journal, 46. https://doi.org/10.1093/eurheartj/ehaf784.3330

Backston, K. J., Morgan, J. A., Patel, S. B., Koka, R., Hu, J., & Raina, R. (2025). Oxidative stress and endothelial dysfunction: The pathogenesis of pediatric hypertension. International Journal of Molecular Sciences, 26(11), Article 5355. https://doi.org/10.3390/ijms26115355

Drożdż, D., Drożdż, M., & Wójcik, M. (2022). Endothelial dysfunction as a factor leading to arterial hypertension. Pediatric Nephrology, 38(9), 2973–2985. https://doi.org/10.1007/s00467-022-05802-z

Gaybiyev, A., & Bobojonov, S. (2025). Laboratory and clinical correlates of early metabolic syndrome in young adults. International Journal of Medical Sciences and Clinical Research, 5(10), 64–69. https://doi.org/10.37547/ijmscr/volume05issue10-15

Jacobs, A., Kruger, R., Smith, W., Mokhaneli, M. C., & Mels, C. M. C. (2025). Profiling endothelial function, oxidative stress, and inflammatory biomarkers in individuals with cardiovascular risk factors. Hypertension Research, 48(12), 3209–3220. https://doi.org/10.1038/s41440-025-02392-9

Latif, S. (2025). Predictive value of serum uric acid, hs-CRP, and microalbuminuria for hypertension development in young adults. European Journal of Clinical Pharmacy, 7(1), 5647–5651. https://doi.org/10.61336/ejcp/25-01-637

Martínez-Casales, M., Hernanz, R., & Alonso, M. J. (2021). Vascular and macrophage heme oxygenase-1 in hypertension: A mini-review. Frontiers in Physiology, 12, Article 643435. https://doi.org/10.3389/fphys.2021.643435

Matraguna, N., Liliana, B.-T., Svetlana, C., Titei, D., & Revenco, N. (2025). The role of oxidative stress in arterial hypertension in obese children with a positive family history. Archives of the Balkan Medical Union, 60(3), 359–364. https://doi.org/10.31688/abmu.2025.60.3.05

Micieta, V., Čeháková, M., & Tonhajzerová, I. (2025). Endothelial dysfunction in adolescent hypertension: Diagnostic challenges and early cardiovascular risk. Journal of Cardiovascular Development and Disease, 12(9), Article 326. https://doi.org/10.3390/jcdd12090326

O’g’li, M. A. A., Qizi, S. U. A., O’g’li, A. J. B., & Centre, W. K. P. (2026a). Increasing prevalence of arterial hypertension among young people: Etiological factors and preventive strategies [Data set]. Zenodo. https://doi.org/10.5281/zenodo.18646159

O’g’li, M. A. A., Qizi, S. U. A., O’g’li, A. J. B., & Centre, W. K. P. (2026b). Increasing prevalence of arterial hypertension among young people: Etiological factors and preventive strategies [Data set]. Zenodo. https://doi.org/10.5281/zenodo.18646158

Oliveira, A. P. D. S., Gomes, P., Matos, A., Miguel, J. P., Freitas, G., Bicho, M. C., & Bicho, M. (2022). Major impact prediction cardiovascular risk in young adults. Journal of Hypertension, 40. https://doi.org/10.1097/01.hjh.0000836012.90277.18

Omar, W. F. N. W., Abdullah, A., Talib, N., Bakrim, N. M., & Musa, N. A. M. (2021). Inflammation precedes sodium retention in raised blood pressure in young adults. International Islamic University Malaysia Repository. http://irep.iium.edu.my/id/eprint/93642

Ryter, S. W. (2022). Heme oxygenase-1: An anti-inflammatory effector in cardiovascular, lung, and related metabolic disorders. Antioxidants, 11(3), Article 555. https://doi.org/10.3390/antiox11030555

Triantafyllidi, H., Benas, D., Pavlidis, G., Ikonomidis, I., Attilakos, A., Iliodromitis, E., & Dretsiou, E. (2025). Interrelationship of cardiovascular risk factors in early adulthood. European Heart Journal, 46. https://doi.org/10.1093/eurheartj/ehaf784.4030

Wu, X., Wei, J., Yi, Y., Gong, Q., & Gao, J. (2022). Activation of Nrf2 signaling: A key molecular mechanism of protection against cardiovascular diseases. Frontiers in Pharmacology, 13, Article 1057918. https://doi.org/10.3389/fphar.2022.1057918

Baoum, S., Alamri, M., Bana, R., Alsulaim, K., Alzahrani, A., Aboqarn, L., Altamimi, Y., Aljabri, F., Abubaker, S., Baflah, R., & Yahya, A. A. (2023). Hypertension in young adults: Causes, management, and lifestyle modification. Journal of Healthcare Sciences, 3(7), 202–209. https://doi.org/10.52533/johs.2023.30702

Chong, B., Kong, G., Shankar, K., et al. (2023). The global syndemic of metabolic diseases in young adults. Metabolism, 141, Article 155402. https://doi.org/10.1016/j.metabol.2023.155402

Howaidy, S. H., Chaloob, E. K., & Aboud, G. A. T. (2022). Age-related changes in blood pressure among young adults. Journal of Pharmaceutical Negative Results, 317–320. https://doi.org/10.47750/pnr.2022.13.s07.043

Jalo, R. I., Bamgboye, E., Salawu, M. M., et al. (2025). Gender disparities in hypertension among young adults in Nigeria. BMC Cardiovascular Disorders, 25, Article 151. https://doi.org/10.1186/s12872-025-04603-0

Meher, M., Pradhan, S., & Pradhan, S. R. (2023). Risk factors associated with hypertension in young adults. Cureus, 15(4), Article e37467. https://doi.org/10.7759/cureus.37467

Naik, S., Ramalingaiah, M. T., & Ram, A. N. (2025). Clinical and etiological profile of hypertension in young patients. Asian Journal of Medical Sciences, 16(1), 49–54. https://doi.org/10.71152/ajms.v16i1.4358

Shin, D., Choi, J., & Lee, H. (2023). Suboptimal control status of young hypertensive population. Clinical Hypertension, 29, Article 13. https://doi.org/10.1186/s40885-023-00237-6

Suh, S. H., Song, S. H., Choi, H. S., et al. (2021). Parental educational status predicts hypertension in young adults. Scientific Reports, 11, Article 3698. https://doi.org/10.1038/s41598-021-83205-0

Abolhasani, M., et al. (2021). Anthropometric and metabolic index in hypertension prediction. Integrated Blood Pressure Control, 153–161. https://doi.org/10.2147/IBPC.S340664

Adegoke, O., et al. (2021). Obesity and blood pressure correlation in Lagos. Scientific Reports, 11, Article 3522. https://doi.org/10.1038/s41598-021-83055-w

Alvi, M., et al. (2024). BMI and cardiovascular risk. Pakistan Journal of Biotechnology, 21(2), 540–549. https://doi.org/10.34016/pjbt.2024.21.02.965

Bhardwaj, S., & Passey, N. (2025). Obesity duration and hypertension severity. SSR Institute Journal of Life Sciences, 11(5), 8362–8368. https://doi.org/10.21276/ssr-iijls.2025.11.5.24

Cai, Q., et al. (2023). Obesity status and hypertension onset. Frontiers in Public Health, 11, Article 1170334. https://doi.org/10.3389/fpubh.2023.1170334

Corsi, D. R., & Agbaje, A. O. (2025). Pediatric adiposity cutoff predicts hypertension. European Heart Journal, 46. https://doi.org/10.1093/eurheartj/ehaf784.3758

Fabi, M., et al. (2023). BMI and cardiac mass in children. Nutrients, 15(24), Article 5079. https://doi.org/10.3390/nu15245079

Gui, J., et al. (2024). Obesity-related indices and hypertension risk. BMC Geriatrics, 24, Article 77. https://doi.org/10.1186/s12877-023-04650-2

Josipović, J., et al. (2025). BMI and cardiometabolic parameters. Journal of Hypertension, 43. https://doi.org/10.1097/01.hjh.0001117156.98997.4b

Kirema, J., et al. (2025). Nutritional status and blood pressure. African Journal of Food, Agriculture, Nutrition and Development, 25(7), 27196–27217. https://doi.org/10.18697/ajfand.144.25970

Martín, P. B. P., et al. (2021). Resting metabolic rate in hypertensive patients. Scandinavian Journal of Medicine & Science in Sports, 31(7), 1461–1470. https://doi.org/10.1111/sms.13955

Oseni, T. I. A., et al. (2023). Obesity and blood pressure control in Nigeria [Preprint]. Research Square. https://doi.org/10.21203/rs.3.rs-3312758/v1

Sena, B. dos S., et al. (2022). Visceral adiposity and cardiometabolic risk. Archives of Endocrinology and Metabolism, 67(2), 224–232. https://doi.org/10.20945/2359-3997000000536

Tan, L., et al. (2023). BMI trajectory and hypertension risk. Frontiers in Cardiovascular Medicine, 9, Article 941341. https://doi.org/10.3389/fcvm.2022.941341

Taurio, J., et al. (2023). Abdominal obesity and hypertension. BMC Cardiovascular Disorders, 23, Article 161. https://doi.org/10.1186/s12872-023-03150-w

Wang, J., et al. (2023). Obesity index and hypertension in older adults. Frontiers in Public Health, 11, Article 1210669. https://doi.org/10.3389/fpubh.2023.1210669

Wu, L., et al. (2022). Anthropometric measures and hypertension. Frontiers in Cardiovascular Medicine, 9, Article 1050654. https://doi.org/10.3389/fcvm.2022.1050654

Zhang, W., et al. (2021). BMI and blood pressure in older adults. BMC Geriatrics, 21, Article 260. https://doi.org/10.1186/s12877-021-02154-5

Zhang, X., et al. (2023). Obesity indices and hypertension risk. Scientific Reports, 13, Article 7776. https://doi.org/10.1038/s41598-023-34969-0

Zuo, C., et al. (2025). Obesity, inflammation index, and uric acid in hypertension. Scientific Reports, 15, Article 35704. https://doi.org/10.1038/s41598-025-19468-8